FDA Inspection 1301080 — Diasorin Inc.
The FDA completed an inspection of Diasorin Inc. on January 13, 2026 in Stillwater, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 13, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Stillwater, MN (United States)
Additional Details
Sponsor, Contract Research Organization